BIPHENOTYPIC ACUTE LEUKEMIA
Clinical trials for BIPHENOTYPIC ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new BIPHENOTYPIC ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for BIPHENOTYPIC ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for babies with leukemia: immunotherapy combo trial launches
Disease control Recruiting nowThis study tests a new treatment plan for infants (up to 12 months old) with a type of leukemia called acute lymphoblastic leukemia. The goal is to see if adding an immunotherapy drug called blinatumomab can better clear leukemia cells that remain after initial treatment. About 9…
Matched conditions: BIPHENOTYPIC ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Tanja Andrea Gruber • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New stem cell transplant method aims to cut complications in young blood cancer patients
Disease control Recruiting nowThis pilot study tests a stem cell transplant method that removes specific immune cells (alpha/beta T cells and B cells) from the donor cells before transplant. The goal is to reduce the risk of graft-versus-host disease, a serious complication, while still allowing the transplan…
Matched conditions: BIPHENOTYPIC ACUTE LEUKEMIA
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo therapy aims to boost leukemia remission
Disease control Recruiting nowThis study tests adding venetoclax to a standard chemotherapy regimen (CLAG-M) for people with acute myeloid leukemia (AML) or related high-grade blood cancers. The goal is to find the safest dose and see if the combination improves cancer control. About 62 participants will take…
Matched conditions: BIPHENOTYPIC ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for tough leukemia: capivasertib combo enters human trials
Disease control Recruiting nowThis study tests whether adding the experimental drug capivasertib to a standard treatment (venetoclax plus low-intensity chemotherapy) is safe and effective for adults with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma that has come back or not responded to prior …
Matched conditions: BIPHENOTYPIC ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Massive blood cancer registry aims to unlock secrets of adult ALL
Knowledge-focused Recruiting nowThis study is a large registry that will collect medical information and biological samples from up to 10,000 adults with acute lymphoblastic leukemia (ALL) and related blood cancers. The goal is to track how patients are diagnosed, treated, and how they fare over time. By gather…
Matched conditions: BIPHENOTYPIC ACUTE LEUKEMIA
Sponsor: Goethe University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC